"GV-backed Startup Shifts Focus to Activating Cancer Cell Proteins for Potential New Medicine"
Researchers from the Broad Institute have discovered that hyperactivating certain signals in three major cancer-driving pathways can effectively inhibit tumor cells. By exploring over 500 cell lines, they found that this approach could potentially be applied widely to kill tumor cells, offering a new avenue for cancer drug development.